{"id":"W4405374515","doi":"10.1016/j.iotech.2024.100846","title":"103P Tislelizumab combined with chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter, prospective, single-arm, real-world study","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Esophageal squamous cell carcinoma; Medicine; Chemoradiotherapy; Oncology; Basal cell; Multicenter study; Internal medicine; Carcinoma; Radiation therapy; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008706942,0.001384118,0.004236211,0.0010858,0.0006325548,0.002035554,0.0009542811,0.00206812,0.004303317],"category_scores_gemma":[0.008670549,0.0009570773,0.009419159,0.002609313,0.0007901295,0.001647,0.0009019704,0.001534927,0.0009283774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001187361,"about_ca_system_score_gemma":0.001418815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001210804,"about_ca_topic_score_gemma":0.002234948,"domain_scores_codex":[0.994027,0.003254683,0.001041941,0.0008420406,0.0005733771,0.0002609192],"domain_scores_gemma":[0.9938865,0.001934294,0.00259824,0.0005209433,0.0006404195,0.000419528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5611461,0.009741317,0.08552757,0.05896864,0.2323556,0.0006849301,0.0004778825,0.0008582693,0.003173012,0.0002553516,0.001986476,0.04482485],"study_design_scores_gemma":[0.2696197,0.129393,0.1696646,0.008245338,0.4080402,0.001332034,0.0007750478,0.001154556,0.00157664,0.0004845479,0.009462917,0.0002514595],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8106195,0.1751095,0.001425003,0.0005792037,0.0004149577,0.006280574,0.003127455,0.00006946024,0.002374281],"genre_scores_gemma":[0.9723522,0.01885472,0.001885489,0.0009510656,0.000284356,0.003332806,0.001656068,0.00001938107,0.0006639575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008706942,"threshold_uncertainty_score":0.04604727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01325214264849089,"score_gpt":0.3187447232035502,"score_spread":0.3054925805550593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}